Pharmacogenomics-CD ComputaBio

Vivian Smith30 Jun, 2024Health

With drastically decreasing costs of genetic sequencing, it has become feasible to use individual genetic markers to optimize treatment selection in cancer therapy. However, it is still difficult for medical practitioners to integrate these new kinds of data into clinical routine, since available information is growing rapidly. Pharmacogenomics (PGx) is one of the core elements of personalized medicine. PGx information reduces the likelihood of adverse drug reactions (ADRs) and optimizes therapeutic efficacy. The advancement of new technologies, including SNP genotyping and microarray/biochips, have been among the key drivers for the implementation of personalized medicine in practice.